Francis Burrows

5PUBLICATIONS
65CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 25, 2026
Farnesyl transferase inhibitor KO-2806 (darlifarnib) enhances the anti-tumor activity of tyrosine kinase inhibitors in RCC.

Jovylyn G Gasendo, Stacia Chan, Hetika V Patel

|Mar 04, 2026
Targeting Menin in T-lineage Acute Lymphoblastic Leukemia.

Kathryn Shimamoto, Diren Arda Karaoglu, Olivia Arnold

|Feb 09, 2026
The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition.

Hetika Vora Patel, Alison Elizabeth Smith, Stacia Chan

|Feb 08, 2023
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.

Sankar Jagadeeshan, Manu Prasad, Mai Badarni

Pageof 1